halothane has been researched along with Rheumatic Heart Disease in 3 studies
Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yared, JP | 1 |
| Estafanous, FG | 2 |
| Zurick, AM | 1 |
| Tarazi, RC | 1 |
| Viljoen, JF | 1 |
| el-Tawil, MY | 1 |
3 other studies available for halothane and Rheumatic Heart Disease
| Article | Year |
|---|---|
Anesthesia for patients with mitral valve disease secondary to rheumatic and coronary artery disease.
Topics: Aged; Anesthesia, General; Coronary Disease; Fentanyl; Halothane; Heart; Hemodynamics; Humans; Middl | 1984 |
Systemic hypertension following myocardial revascularization.
Topics: Adult; Analgesics; Anesthesia, Inhalation; Blood Pressure; Coronary Artery Bypass; Coronary Disease; | 1973 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1970.
Topics: Aged; Autopsy; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Diagnosis, Diffe | 1970 |